Search
Search Constraints
You searched for: Author/Creator Larner, James M.- Larner, James M. [remove] 5
- 572 2
- Periodicals 2
- 616.994 1
- 616.99424 1
- 616.99494005 1
- AE adverse event -- AUC area under the curve -- BID twice daily -- CI confidence interval -- Cmax maximum observed concentration -- CP carboplatin/paclitaxel -- CR complete response -- CRT chemoradiotherapy -- DLT dose-limiting toxicities -- DOR duration of response -- ECOG Eastern Cooperative Oncology Group -- FEV1 forced expiratory volume in one second -- KM Kaplan-Meier -- mPFS median progression-free survival -- MTD maximum tolerated dose -- N node -- NSCLC non-small cell lung cancer -- ORR objective response rate -- OS overall survival -- PARP poly(ADP)-ribose polymerase -- PFS progression-free survival -- PK pharmacokinetics -- PR partial response -- RECIST Response Evaluation Criteria in Solid Tumors -- RP2D recommended phase 2 dose -- RT radiotherapy -- T tumor -- TEAE treatment-emergent adverse event -- Tmax time to Cmax -- V20 volume of lung to receive ≥20 Gy RT 1
- Biochemistry -- Congresses 1
- Biochemistry -- Periodicals 1
- Carcinoma, non‐small cell lung -- dose fractionation, radiation -- lung neoplasms -- patient selection -- radiosurgery 1
- Chest -- Cancer -- Periodicals 1